Osmetech Change to GenMark Gets OK from UK Court | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Osmetech announced over the weekend that the High Court of Justice in England and Wales has sanctioned the company's plan to float in the US and the Capital Reduction by which GenMark's purchase of Osmetech is being implemented.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.